A
-
Anticancer
Synthesis, Molecular Modeling and Anticancer Activity of New Rescinnamine Derivatives as MMR-Inducers [Volume 2, Issue 1, 2023, Pages 21-35]
-
Autoimmune
A potential therapy for the Rheumatoid Arthritis: New drug discovery [Volume 2, Issue 1, 2023, Pages 11-20]
B
-
Biologics
A potential therapy for the Rheumatoid Arthritis: New drug discovery [Volume 2, Issue 1, 2023, Pages 11-20]
C
-
Citrullination
A potential therapy for the Rheumatoid Arthritis: New drug discovery [Volume 2, Issue 1, 2023, Pages 11-20]
-
Corona virus
Review article on instrumental analysis of Molnupiravir, Favipiravir, and Ritonavir in different matrices [Volume 2, Issue 1, 2023, Pages 36-43]
F
-
Favipiravir
Review article on instrumental analysis of Molnupiravir, Favipiravir, and Ritonavir in different matrices [Volume 2, Issue 1, 2023, Pages 36-43]
H
-
Heck
Synthesis, Molecular Modeling and Anticancer Activity of New Rescinnamine Derivatives as MMR-Inducers [Volume 2, Issue 1, 2023, Pages 21-35]
K
-
Key Words: HPLC
Determination of alogliptin benzoate and pioglitazone hydrochloride in their dosage forms, validation and stability-indicating studies using RP-HPLC method. [Volume 2, Issue 1, 2023, Pages 1-10]
M
-
MMP-1
Design, synthesis in vitro and in vivo evaluation of new diaryltriazoles carboxylic and hydroxamic acid derivatives as inhibitors of tumor necrosis alpha converting enzyme (TACE) [Volume 2, Issue 1, 2023, Pages 44-62]
-
MMR
Synthesis, Molecular Modeling and Anticancer Activity of New Rescinnamine Derivatives as MMR-Inducers [Volume 2, Issue 1, 2023, Pages 21-35]
-
Molnupiravir
Review article on instrumental analysis of Molnupiravir, Favipiravir, and Ritonavir in different matrices [Volume 2, Issue 1, 2023, Pages 36-43]
P
-
Pioglitazone
Determination of alogliptin benzoate and pioglitazone hydrochloride in their dosage forms, validation and stability-indicating studies using RP-HPLC method. [Volume 2, Issue 1, 2023, Pages 1-10]
R
-
Rescinnamine
Synthesis, Molecular Modeling and Anticancer Activity of New Rescinnamine Derivatives as MMR-Inducers [Volume 2, Issue 1, 2023, Pages 21-35]
-
Rheumatoid Arthritis
A potential therapy for the Rheumatoid Arthritis: New drug discovery [Volume 2, Issue 1, 2023, Pages 11-20]
-
Ritonavir
Review article on instrumental analysis of Molnupiravir, Favipiravir, and Ritonavir in different matrices [Volume 2, Issue 1, 2023, Pages 36-43]
S
-
Stability tests
Determination of alogliptin benzoate and pioglitazone hydrochloride in their dosage forms, validation and stability-indicating studies using RP-HPLC method. [Volume 2, Issue 1, 2023, Pages 1-10]
T
-
TACE
Design, synthesis in vitro and in vivo evaluation of new diaryltriazoles carboxylic and hydroxamic acid derivatives as inhibitors of tumor necrosis alpha converting enzyme (TACE) [Volume 2, Issue 1, 2023, Pages 44-62]
Your query does not match with any item